WEKO3
インデックスリンク
アイテム
メタボリックシンドロームモデルラットにおける各種分子量キトサンの抗酸化作用および脂質抑制効果の評価(発表論文抄録(2010))
https://fukuyama-u.repo.nii.ac.jp/records/8842
https://fukuyama-u.repo.nii.ac.jp/records/8842dd4a6129-3116-4a60-b4b9-6a2ce43514ea
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-01-15 | |||||
タイトル | ||||||
タイトル | メタボリックシンドロームモデルラットにおける各種分子量キトサンの抗酸化作用および脂質抑制効果の評価(発表論文抄録(2010)) | |||||
タイトル | ||||||
タイトル | The Antioxidative and Antilipidemic Effects of Different Molecular Weight Chitosans in Metabolic Syndrome Model Rats | |||||
言語 | en | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | metabolic syndrome | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | chitosan | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | antilipidemic effect | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | antioxidant activity | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | departmental bulletin paper | |||||
著者 |
安楽, 誠
× 安楽, 誠× 道原, 明宏× 安福, 平× 赤崎, 健司× 土谷, 大樹× 西尾, 廣昭× 丸山, 徹× 小田切, 優樹× 前崎, 祐二× 近藤, 裕子× 冨田, 久夫 |
|||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46274 | |||||
姓名 | Anraku, Makoto | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46275 | |||||
姓名 | Michihara, Akihiro | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46276 | |||||
姓名 | Yasufuku, Taira | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46277 | |||||
姓名 | Akasaki, Kenji | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46278 | |||||
姓名 | Tsuchiya, Daiju | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46279 | |||||
姓名 | Nishio, Hiroaki | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46280 | |||||
姓名 | Maruyama, Toru | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46281 | |||||
姓名 | Otagiri, Masaki | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46282 | |||||
姓名 | Maezaki, Yuji | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46283 | |||||
姓名 | Kondo, Yuko | |||||
著者別名 | ||||||
識別子Scheme | WEKO | |||||
識別子 | 46284 | |||||
姓名 | Tomida, Hisao | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The effect of high and low molecular weight chitosans (HMC; 1000 kDa, LMC; 30 kDa) on oxidative stress and hypercholesterolemia was investigated using male 6-week-old Wistar Kyoto rats as a normal model (Normal-rats) and spontaneously hypertensive rat/ND mcr-cp (SHP/ND) as a metabolic syndrome model (MS-rats), respectively. In Normal-rats, the ingestion of both chitosans over a 4 week period resulted in a significant decrease in total body weight (BW), glucose (Gl), triglyceride (TG), low density lipoprotein (LDL) and serum creatinine (Cre) levels. The ingestion of both chitosans also resulted in a lowered ratio of oxidized to reduced albumin and an increase in total plasma antioxidant activity. In addition to similar results in Normal-rats, the ingestion of only HMC over a 4 week period resulted in a significant decrease in total cholesterol levels in MS-rats. Further, the ingestion of LMC resulted in a significantly higher antioxidant activity than was observed for HMC in both rat models. In in vitro studies, LMC caused a significantly higher reduction in the levels of two stable radicals, compared to HMC, and the effect was both dose- and time-dependent. The findings also show that LDL showed strong binding in the case of HMC. These results suggest that LMC has a high antioxidant activity as well as antilipidemic effects, while HMC results in a significant reduction in the levels of pro-oxidants such as LDL in the gastrointestinal tract, thereby inhibiting the subsequent development of oxidative stress in the systemic circulation in metabolic model rats. | |||||
内容記述 | ||||||
内容記述タイプ | Other | |||||
内容記述 | The effect of high and low molecular weight chitosans (HMC; 1000 kDa, LMC; 30 kDa) on oxidative stress and hypercholesterolemia was investigated using male 6-week-old Wistar Kyoto rats as a normal model (Normal-rats) and spontaneously hypertensive rat/ND mcr-cp (SHP/ND) as a metabolic syndrome model (MS-rats), respectively. In Normal-rats, the ingestion of both chitosans over a 4 week period resulted in a significant decrease in total body weight (BW), glucose (Gl), triglyceride (TG), low density lipoprotein (LDL) and serum creatinine (Cre) levels. The ingestion of both chitosans also resulted in a lowered ratio of oxidized to reduced albumin and an increase in total plasma antioxidant activity. In addition to similar results in Normal-rats, the ingestion of only HMC over a 4 week period resulted in a significant decrease in total cholesterol levels in MS-rats. Further, the ingestion of LMC resulted in a significantly higher antioxidant activity than was observed for HMC in both rat models. In in vitro studies, LMC caused a significantly higher reduction in the levels of two stable radicals, compared to HMC, and the effect was both dose- and time-dependent. The findings also show that LDL showed strong binding in the case of HMC. These results suggest that LMC has a high antioxidant activity as well as antilipidemic effects, while HMC results in a significant reduction in the levels of pro-oxidants such as LDL in the gastrointestinal tract, thereby inhibiting the subsequent development of oxidative stress in the systemic circulation in metabolic model rats. | |||||
書誌情報 |
福山大学薬学部研究年報 en : Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University 号 29, p. 51-52, 発行日 2011-12-25 |
|||||
出版者 | ||||||
出版者 | 福山大学薬学部研究年報 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0288-724X | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN10064550 |